CN102408423A - 一种制备大粒径达沙替尼的方法 - Google Patents
一种制备大粒径达沙替尼的方法 Download PDFInfo
- Publication number
- CN102408423A CN102408423A CN2011103880461A CN201110388046A CN102408423A CN 102408423 A CN102408423 A CN 102408423A CN 2011103880461 A CN2011103880461 A CN 2011103880461A CN 201110388046 A CN201110388046 A CN 201110388046A CN 102408423 A CN102408423 A CN 102408423A
- Authority
- CN
- China
- Prior art keywords
- dasatinib
- particle diameter
- obtains
- big particle
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110388046 CN102408423B (zh) | 2011-11-29 | 2011-11-29 | 一种制备大粒径达沙替尼的方法 |
PCT/CN2012/085282 WO2013078973A1 (zh) | 2011-11-29 | 2012-11-26 | 一种大粒径达沙替尼及其制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110388046 CN102408423B (zh) | 2011-11-29 | 2011-11-29 | 一种制备大粒径达沙替尼的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102408423A true CN102408423A (zh) | 2012-04-11 |
CN102408423B CN102408423B (zh) | 2013-12-25 |
Family
ID=45910810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110388046 Active CN102408423B (zh) | 2011-11-29 | 2011-11-29 | 一种制备大粒径达沙替尼的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102408423B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013078973A1 (zh) * | 2011-11-29 | 2013-06-06 | 上海创诺制药有限公司 | 一种大粒径达沙替尼及其制备和应用 |
CN103819469A (zh) * | 2012-11-16 | 2014-05-28 | 重庆医药工业研究院有限责任公司 | 一种达沙替尼的晶型及其制备方法 |
CN104341410A (zh) * | 2013-08-09 | 2015-02-11 | 上海科胜药物研发有限公司 | 一种达沙替尼新晶型及其制备方法 |
CN107157941A (zh) * | 2017-05-16 | 2017-09-15 | 北京化工大学 | 一种达沙替尼纳米制剂及其制备方法 |
CN110862387A (zh) * | 2018-08-27 | 2020-03-06 | 鲁南制药集团股份有限公司 | 一种达沙替尼新晶型及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009053854A2 (en) * | 2007-10-23 | 2009-04-30 | Teva Pharmaceutical Industries Ltd. | Polymorphs of dasatinib and process for preparation thereof |
WO2010139979A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
WO2010139981A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
-
2011
- 2011-11-29 CN CN 201110388046 patent/CN102408423B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009053854A2 (en) * | 2007-10-23 | 2009-04-30 | Teva Pharmaceutical Industries Ltd. | Polymorphs of dasatinib and process for preparation thereof |
WO2010139979A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
WO2010139981A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013078973A1 (zh) * | 2011-11-29 | 2013-06-06 | 上海创诺制药有限公司 | 一种大粒径达沙替尼及其制备和应用 |
CN103819469A (zh) * | 2012-11-16 | 2014-05-28 | 重庆医药工业研究院有限责任公司 | 一种达沙替尼的晶型及其制备方法 |
CN104341410A (zh) * | 2013-08-09 | 2015-02-11 | 上海科胜药物研发有限公司 | 一种达沙替尼新晶型及其制备方法 |
CN107157941A (zh) * | 2017-05-16 | 2017-09-15 | 北京化工大学 | 一种达沙替尼纳米制剂及其制备方法 |
CN110862387A (zh) * | 2018-08-27 | 2020-03-06 | 鲁南制药集团股份有限公司 | 一种达沙替尼新晶型及其制备方法 |
CN110862387B (zh) * | 2018-08-27 | 2023-05-16 | 鲁南制药集团股份有限公司 | 一种达沙替尼新晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102408423B (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102408423B (zh) | 一种制备大粒径达沙替尼的方法 | |
EP3328831B1 (en) | A method for preparing methyl (z)-3-[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene)-oxindole-6-carboxylate (intedanib, nintedanib) | |
CN101768199B (zh) | 醋酸阿比特龙的多晶型物及其制备方法 | |
US20190194146A1 (en) | 6-bromo-3-hydroxy-2-pyrazinecarboxamide crystal and method for producing same | |
CN104530086B (zh) | 头孢孟多酯钠化合物的新晶型及其结晶制备方法 | |
CN105061420B (zh) | 一种jak抑制剂的晶型及其制备方法和应用 | |
CN103709139A (zh) | 无水右兰索拉唑的制备方法 | |
KR20160014620A (ko) | 디벤질아민 구조를 갖는 피리미딘 화합물의 신규 형태 | |
CN104193766A (zh) | 一种头孢他美酸的制备方法 | |
CN102757388B (zh) | 一种高纯度英加韦林的制备方法 | |
US8962833B2 (en) | Salts of raltegravir | |
CN104418857A (zh) | 无定型利格列汀及其制备方法 | |
WO2012164575A2 (en) | Amorphous ritonavir co-precipitated | |
JP5827684B2 (ja) | 2−[3−シアノ−4−(2−i−ブトキシ)フェニル]−4−メチル−5−チアゾール−カルボン酸(フェブキソスタット)の結晶形Aを調製するための方法 | |
CN106831709B (zh) | 右旋兰索拉唑-异烟碱共晶及其应用 | |
CN103059013A (zh) | 达沙替尼一水合物的新晶形及其制备方法 | |
CN104086544A (zh) | 阿哌沙班一水合物及其制备方法和药物组合物 | |
CA2914669A1 (en) | Crystalline imatinib mesylate process | |
CN105237529A (zh) | 高纯度无水达沙替尼的精制方法 | |
WO2010079498A2 (en) | Novel polymorph of sorafenib tosylate | |
CN107814769B (zh) | 一种博舒替尼的纯化方法 | |
CN105523994B (zh) | 甲磺酸洛美他派晶型iii | |
CN104326983A (zh) | 一种塞来昔布的精制方法 | |
EP3512854A1 (en) | Process for the preparation of pure and stable crystalline raltegravir potassium form 3 | |
CN104211693A (zh) | 一种利伐沙班新晶型及其制备方法与用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI CHUANGNUO PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHANGHAI XIDI PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Pudong New Area Huinan town 201300 Hunan Road Shanghai City No. 9125 Patentee after: SHANGHAI ACEBRIGHT PHARMACEUTICALS Co.,Ltd. Address before: Pudong New Area Huinan town 201300 Hunan Road Shanghai City No. 9125 Patentee before: Shanghai Xidi Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221206 Address after: No. 9125 Hunan Highway, Huinan Town, Pudong New Area, Shanghai, 201300 Patentee after: SHANGHAI ACEBRIGHT PHARMACEUTICALS Co.,Ltd. Patentee after: JIANGSU XIDI PHARMACEUTICAL Co.,Ltd. Address before: No. 9125 Hunan Highway, Huinan Town, Pudong New Area, Shanghai, 201300 Patentee before: SHANGHAI ACEBRIGHT PHARMACEUTICALS Co.,Ltd. |